October 6, 2017

Amgen Inc v. Genentech, Inc. et al

Track this case

Case Number:

2:17-cv-07349

Court:

California Central

Nature of Suit:

830(Patent)

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 6, 2017

    Amgen Sues Genentech To Shield Avastin Biosimilar

    Amgen Inc. filed a suit in California federal court Friday seeking a declaration that 27 patents related to Genentech’s cancer treatment Avastin are invalid, unenforceable and aren’t infringed by Amgen’s biologic, which won U.S. Food and Drug Administration approval last month.


Parties

To view the parties, register now.